A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral
therapy in participants with inadequately controlled asthma with an eosinophilic phenotype
and a history of asthma exacerbations.